BriaCell Therapeutics (BCT) Competitors C$19.16 +0.93 (+5.10%) As of 10/24/2025 03:14 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock BCT vs. SCYB, COM, NVH, IGX, MDNA, PDP, SVA, COV, EMH, and PMNShould you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), Medicenna Therapeutics (MDNA), Pediapharm (PDP), Sernova (SVA), Covalon Technologies (COV), Emerald Health Therapeutics (EMH), and ProMIS Neurosciences (PMN). These companies are all part of the "biotechnology" industry. BriaCell Therapeutics vs. Its Competitors Scythian Biosciences 138267 (COM.TO) Novoheart IntelGenx Technologies Medicenna Therapeutics Pediapharm Sernova Covalon Technologies Emerald Health Therapeutics ProMIS Neurosciences BriaCell Therapeutics (TSE:BCT) and Scythian Biosciences (CVE:SCYB) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability. Is BCT or SCYB more profitable? BriaCell Therapeutics' return on equity of 536.29% beat Scythian Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets BriaCell TherapeuticsN/A 536.29% -122.71% Scythian Biosciences N/A N/A N/A Do insiders and institutionals hold more shares of BCT or SCYB? 0.0% of BriaCell Therapeutics shares are held by institutional investors. 9.3% of BriaCell Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has preferable valuation and earnings, BCT or SCYB? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBriaCell TherapeuticsN/AN/A-C$2.37M-C$62.19-0.31Scythian BiosciencesN/AN/AN/AN/AN/A Does the media prefer BCT or SCYB? In the previous week, BriaCell Therapeutics had 1 more articles in the media than Scythian Biosciences. MarketBeat recorded 1 mentions for BriaCell Therapeutics and 0 mentions for Scythian Biosciences. Scythian Biosciences' average media sentiment score of 0.00 beat BriaCell Therapeutics' score of -1.32 indicating that Scythian Biosciences is being referred to more favorably in the news media. Company Overall Sentiment BriaCell Therapeutics Negative Scythian Biosciences Neutral SummaryBriaCell Therapeutics beats Scythian Biosciences on 4 of the 6 factors compared between the two stocks. Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart BCT vs. The Competition Export to ExcelMetricBriaCell TherapeuticsBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$36.10MC$219.07MC$6.23BC$9.66BDividend Yield13.70%3.81%5.71%6.50%P/E Ratio-0.313.2830.4329.41Price / SalesN/A5,399.00595.8210.82Price / CashN/A13.1937.0183.29Price / Book93.0390.1312.045.78Net Income-C$2.37M-C$90.99MC$3.32BC$301.20M7 Day Performance15.84%0.21%1.88%0.79%1 Month Performance27.73%5.28%7.68%2.39%1 Year Performance59.67%495.29%56.01%35.06% BriaCell Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTBriaCell TherapeuticsN/AC$19.16+5.1%N/A+54.5%C$36.10MN/A-0.3116Negative NewsSCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/ANVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423.50K-13.95N/AIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpMDNAMedicenna TherapeuticsN/AC$0.94flatN/A-28.8%C$78.41MN/A-5.8820News CoveragePDPPediapharmN/AC$0.30+1.7%N/A+0.0%C$66.36MC$11.16M-4.11N/ASVASernovaN/AC$0.17-8.1%N/A-35.3%C$55.88MN/A-3.401,959Gap DownCOVCovalon TechnologiesN/AC$2.01-3.8%N/A-30.6%C$55.11MC$32.99M22.33N/AEMHEmerald Health TherapeuticsN/AC$0.26-3.8%N/A+0.0%C$52.28MC$13.02M-0.37161PMNProMIS NeurosciencesN/AN/AN/AN/AC$51.48MC$7.56K-1.786Positive NewsGap UpHigh Trading Volume Related Companies and Tools Related Companies SCYB Alternatives COM Alternatives NVH Alternatives IGX Alternatives MDNA Alternatives PDP Alternatives SVA Alternatives COV Alternatives EMH Alternatives PMN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:BCT) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCT Stock Alerts